184 related articles for article (PubMed ID: 24582884)
1. Inhibitors of NF-kappaB reverse cellular invasion and target gene upregulation in an experimental model of aggressive oral squamous cell carcinoma.
Johnson J; Shi Z; Liu Y; Stack MS
Oral Oncol; 2014 May; 50(5):468-77. PubMed ID: 24582884
[TBL] [Abstract][Full Text] [Related]
2. Selective inhibition of NF-κB suppresses bone invasion by oral squamous cell carcinoma in vivo.
Furuta H; Osawa K; Shin M; Ishikawa A; Matsuo K; Khan M; Aoki K; Ohya K; Okamoto M; Tominaga K; Takahashi T; Nakanishi O; Jimi E
Int J Cancer; 2012 Sep; 131(5):E625-35. PubMed ID: 22262470
[TBL] [Abstract][Full Text] [Related]
3. Protease-activated Receptor-2 (PAR-2)-mediated Nf-κB Activation Suppresses Inflammation-associated Tumor Suppressor MicroRNAs in Oral Squamous Cell Carcinoma.
Johnson JJ; Miller DL; Jiang R; Liu Y; Shi Z; Tarwater L; Williams R; Balsara R; Sauter ER; Stack MS
J Biol Chem; 2016 Mar; 291(13):6936-45. PubMed ID: 26839311
[TBL] [Abstract][Full Text] [Related]
4. Selective inhibition of nuclear factor-κB by nuclear factor-κB essential modulator-binding domain peptide suppresses the metastasis of highly metastatic oral squamous cell carcinoma.
Tanaka T; Nakayama H; Yoshitake Y; Irie A; Nagata M; Kawahara K; Takamune Y; Yoshida R; Nakagawa Y; Ogi H; Shinriki S; Ota K; Hiraki A; Ikebe T; Nishimura Y; Shinohara M
Cancer Sci; 2012 Mar; 103(3):455-63. PubMed ID: 22136381
[TBL] [Abstract][Full Text] [Related]
5. Utilization of E-cadherin by monocytes from tumour cells plays key roles in the progression of bone invasion by oral squamous cell carcinoma.
Quan J; Du Q; Hou Y; Wang Z; Zhang J
Oncol Rep; 2017 Aug; 38(2):850-858. PubMed ID: 28656299
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of Eps8 in oral squamous cell carcinoma promotes cell migration and invasion through integrin-dependent Rac1 activation.
Yap LF; Jenei V; Robinson CM; Moutasim K; Benn TM; Threadgold SP; Lopes V; Wei W; Thomas GJ; Paterson IC
Oncogene; 2009 Jul; 28(27):2524-34. PubMed ID: 19448673
[TBL] [Abstract][Full Text] [Related]
7. CXCL12/SDF-1 alpha activates NF-kappaB and promotes oral cancer invasion through the Carma3/Bcl10/Malt1 complex.
Rehman AO; Wang CY
Int J Oral Sci; 2009 Sep; 1(3):105-18. PubMed ID: 20695076
[TBL] [Abstract][Full Text] [Related]
8. MCP-1 as a potential target to inhibit the bone invasion by oral squamous cell carcinoma.
Quan J; Morrison NA; Johnson NW; Gao J
J Cell Biochem; 2014 Oct; 115(10):1787-98. PubMed ID: 24905457
[TBL] [Abstract][Full Text] [Related]
9. High expression levels of nuclear factor kappa B and gelatinases in the tumorigenesis of oral squamous cell carcinoma.
Bindhu OS; Ramadas K; Sebastian P; Pillai MR
Head Neck; 2006 Oct; 28(10):916-25. PubMed ID: 16823875
[TBL] [Abstract][Full Text] [Related]
10. Down-regulation of JMJD5 suppresses metastasis and induces apoptosis in oral squamous cell carcinoma by regulating p53/NF-κB pathway.
Yao Y; Zhou WY; He RX
Biomed Pharmacother; 2019 Jan; 109():1994-2004. PubMed ID: 30551455
[TBL] [Abstract][Full Text] [Related]
11. CARD9 downregulation suppresses the growth of oral squamous cell carcinoma by regulating NF-κB.
Ye LJ; Zhou XC; Yin XJ; Shang Y; Xiao Y; Jiang YL; Wen XX
Oral Dis; 2019 Nov; 25(8):1886-1896. PubMed ID: 31306536
[TBL] [Abstract][Full Text] [Related]
12. PER2 binding to HSP90 enhances immune response against oral squamous cell carcinoma by inhibiting IKK/NF-κB pathway and PD-L1 expression.
Zhang Z; Sun D; Tang H; Ren J; Yin S; Yang K
J Immunother Cancer; 2023 Nov; 11(11):. PubMed ID: 37914384
[TBL] [Abstract][Full Text] [Related]
13. The novel IκB kinase β inhibitor IMD-0560 prevents bone invasion by oral squamous cell carcinoma.
Tada Y; Kokabu S; Sugiyama G; Nakatomi C; Aoki K; Fukushima H; Osawa K; Sugamori Y; Ohya K; Okamoto M; Fujikawa T; Itai A; Matsuo K; Watanabe S; Jimi E
Oncotarget; 2014 Dec; 5(23):12317-30. PubMed ID: 25373602
[TBL] [Abstract][Full Text] [Related]
14. Urinary-type plasminogen activator receptor/alpha 3 beta 1 integrin signaling, altered gene expression, and oral tumor progression.
Ghosh S; Koblinski J; Johnson J; Liu Y; Ericsson A; Davis JW; Shi Z; Ravosa MJ; Crawford S; Frazier S; Stack MS
Mol Cancer Res; 2010 Feb; 8(2):145-58. PubMed ID: 20145038
[TBL] [Abstract][Full Text] [Related]
15. Platycodin D, a triterpenoid saponin from Platycodon grandiflorum, suppresses the growth and invasion of human oral squamous cell carcinoma cells via the NF-κB pathway.
Zhang Z; Zhao M; Zheng W; Liu Y
J Biochem Mol Toxicol; 2017 Sep; 31(9):. PubMed ID: 28548219
[TBL] [Abstract][Full Text] [Related]
16. NF-kappaB-dependent transcriptional activation in lung carcinoma cells by farnesol involves p65/RelA(Ser276) phosphorylation via the MEK-MSK1 signaling pathway.
Joo JH; Jetten AM
J Biol Chem; 2008 Jun; 283(24):16391-9. PubMed ID: 18424438
[TBL] [Abstract][Full Text] [Related]
17. Ubiquitin D Promotes Progression of Oral Squamous Cell Carcinoma via NF-Kappa B Signaling.
Song A; Wang Y; Jiang F; Yan E; Zhou J; Ye J; Zhang H; Ding X; Li G; Wu Y; Zheng Y; Song X
Mol Cells; 2021 Jul; 44(7):468-480. PubMed ID: 34230226
[TBL] [Abstract][Full Text] [Related]
18. Knockdown of Gab1 Inhibits Cellular Proliferation, Migration, and Invasion in Human Oral Squamous Carcinoma Cells.
Xu L; Li J; Kuang Z; Kuang Y; Wu H
Oncol Res; 2018 May; 26(4):617-624. PubMed ID: 28893350
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of miR-138 sustains NF-κB activation and promotes lipid raft formation in esophageal squamous cell carcinoma.
Gong H; Song L; Lin C; Liu A; Lin X; Wu J; Li M; Li J
Clin Cancer Res; 2013 Mar; 19(5):1083-93. PubMed ID: 23319823
[TBL] [Abstract][Full Text] [Related]
20. A novel NF-kappaB pathway involving IKKbeta and p65/RelA Ser-536 phosphorylation results in p53 Inhibition in the absence of NF-kappaB transcriptional activity.
Jeong SJ; Pise-Masison CA; Radonovich MF; Park HU; Brady JN
J Biol Chem; 2005 Mar; 280(11):10326-32. PubMed ID: 15611068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
